MCC to reschedule ALL Cannabidiol-containing products to Schedule 4
On the 28th of July the Medicines Control Council, in consultation with the Minister of Health gazetted a regulatory notice scheduling various substances in terms of section 22A(2) of the Medicines and Related Substances Act (Act No. 101 of 1965). One of the substances hidden at the bottom of page 27 of the gazette was Cannabidiol, or more commonly known as CBD. All products imported and sold with claims relating to therapeutic effects were to... Read More